Medico Intercontinental Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Medico Intercontinental Ltd. on BSE

Search Inside the pdf :

Medico Intercontinental Ltd.

08 Apr 2025

39.59

2.19%

Corp. Note

Medico Intercontinental Ltd - 539938 - Format of the Initial Disclosure to be made by an …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyMedico Intercontinental Ltd 2CIN NO.L24100GJ1984PLC111413 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 14.00 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: PUNEETA SHARMA Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER EmailId: mail@medicointercontinental.com Name of the Chief Financial Officer: JAY SHARADKUMAR SHAH Designation: CHIEF FINANCIAL OFFICER EmailId: mail@medicointercontinental.cm Date: 08/04/2025 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf

Medico Intercontinental Ltd.

07 Apr 2025

39.59

2.19%

Company Update

Medico Intercontinental Ltd - 539938 - Announcement under Regulation 30 (LODR)-Meeting Updates

BSE India

Announcement under Regulation 30 (LODR) - Meeting updates

pdf

Medico Intercontinental Ltd.

07 Apr 2025

39.59

2.19%

Corp. Note

Medico Intercontinental Ltd - 539938 - Board Meeting Outcome for In Compliances Of Regulation 30 Of …

BSE India

Outcome of Board meeting

pdf

Medico Intercontinental Ltd.

07 Apr 2025

39.59

2.19%

Company Update

Medico Intercontinental Ltd - 539938 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Confirmation Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018.

pdf

Medico Intercontinental Ltd.

29 Mar 2025

39.59

2.19%

SAST

Medico Intercontinental Ltd - 539938 - Closure of Trading Window

BSE India

Closure of Trading Window

pdf

Medico Intercontinental Ltd.

15 Feb 2025

39.59

2.19%

Company Update

Medico Intercontinental Ltd - 539938 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Announcement under Regulation 30 (LODR) - Newspaper Publication

pdf

Medico Intercontinental Ltd.

14 Feb 2025

39.59

2.19%

Corp. Note

Medico Intercontinental Ltd - 539938 - Integrated Filing (Financial)

BSE India

Integrated Filing (Financial) for the quarter and nine months ended December 31, 2024.

pdf

Medico Intercontinental Ltd.

14 Feb 2025

39.59

2.19%

Result

Medico Intercontinental Ltd - 539938 - Results - Quarter And Nine Months Ended December 31, 2024

BSE India

Results - Quarter and Nine Months ended December 31, 2024

pdf

Medico Intercontinental Ltd.

14 Feb 2025

39.59

2.19%

Board Meeting

Medico Intercontinental Ltd - 539938 - Board Meeting Outcome for Compliances Of Regulation 30, 33 Of …

BSE India

Pursuant to provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e., February 14, 2025, inter alia, considered and approved Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended on December 31, 2024 along with Limited Review Report issued by M/s. V Goswami & Co, Statutory Auditors of the Company. Further, please find enclosed 'Standalone and Consolidated Unaudited Financial Results, along with Limited Review Report' for the quarter and nine months ended on December 31, 2024 as Annexure 1 and same is also available on the website of the Company viz. www.medicointercontinental.com The Board Meeting of the Company commenced at 12:30 PM and concluded at 12:50 PM.

pdf

Medico Intercontinental Ltd.

06 Feb 2025

39.59

2.19%

Board Meeting

Medico Intercontinental Ltd - 539938 - Board Meeting Intimation for Compliance Of Regulation 29, 30 And …

BSE India

Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 ,inter alia, to consider and approve and take on record the unaudited Financial Results (Standalone and Consolidated) for quarter and nine months ended 31st December, 2024 and any other business items as per agenda circulated.

pdf

Is Medico Intercontinental Ltd. worth buying?

33 Votes:

Buy 75.76%

Sell 12.12%

Hold 12.12%